Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gen-Probe secures patent ownership:

This article was originally published in Clinica

Executive Summary

A San Diego District Court jury has ruled that Gen-Probe is the sole owner of two patents relating to ribosomal RNA probe testing. Regents of the University of California filed a suit against Gen-Probe and inventor Dr David Kohne in 1993 claiming that Dr Eric Stanbridge, a UC professor, had co-invented the technology in 1975. The case against Gen-Probe was funded by Amoco which had agreed to indemnify the Regents and Dr Stanbridge if the case were successful in return for a licence to the patents. San Diego-based Gen-Probe is owned by Japanese company Chugai Pharmaceutical.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel